

AEON Biopharma shares are trading lower by 65% during Monday's session. The company announced the pricing of a $20 million offering.
You can purchase shares of AEON Biopharma (AMEX:AEON) through any online brokerage.
Other companies in AEON Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
AEON Biopharma has a consensus price target of $3.47.
The stock price for AEON Biopharma (AMEX: AEON) is $0.1574 last updated November 13, 2026 at 4:00 PM EST.
There are no upcoming dividends for AEON Biopharma.
AEON Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for AEON Biopharma.
AEON Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory...